Ken Block Consulting

Executive Summary

Ken Block Consulting (KBC) is a specialized regulatory affairs consultancy founded in 2010 and headquartered in Paris, France. The firm focuses exclusively on the medical device industry, providing end-to-end support for manufacturers seeking FDA compliance and US market access. Its core services include regulatory strategy, quality system implementation, risk management, validation, and submissions support. By helping clients navigate the complex US regulatory landscape, KBC positions itself as a critical partner for medical device companies, particularly those in the digital health and AI/ML spaces. The consultancy's deep expertise in FDA requirements and its global client base underscore its reputation as a niche but highly capable player in the regulatory affairs segment. Despite being a private firm with no disclosed funding, KBC's longevity—over 15 years—indicates steady demand and operational resilience. The company is well-placed to benefit from increasing regulatory scrutiny and the growing complexity of bringing medical devices to market, especially as AI-driven technologies proliferate. However, its limited scale and dependence on the US market expose it to regulatory changes and competitive pressures from larger consulting firms. Overall, KBC represents a specialized service provider with a defensible niche and moderate growth potential.

Upcoming Catalysts (preview)

• Q3 2026FDA finalizes guidance on AI/ML-enabled medical devices85% success
• Q4 2026KBC expands service offering to include EU MDR transition support70% success
• Q2 2026Partnership with a major medtech firm for regulatory outsourcing45% success